EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial

Ghasem Rahmatpour Rokni, Mohammad Malekan, Sepide Azade, Amir Mohammad Beyzaee, Keyvan Heydari, Sahar Fallah, Armaghan Kazeminejad, Shirin Zaresharifi, Nasim Gholizadeh

Lasers in Medical Science · 15.01.2025 · 40 (1)

DOI: 10.1007/s10103-025-04293-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, online erschienen am 15.01.2025. Verfasst von Ghasem Rahmatpour Rokni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Vitiligo, Lasers, Gas, Ultraviolet Therapy, Low-Level Light Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a chronic depigmenting condition that causes amelanotic macules and patches on the skin. Despite various treatment options, treating vitiligo is a challenge. This study aimed to evaluate the combination of laser CO2 fractional and narrow-band ultraviolet B (NB-UVB) versus NB-UVB monotherapy in vitiligo patients. This was a prospective, self-controlled, and randomized trial. Ten patients with symmetrical vitiligo lesions on both sides of their body and who had a history of insufficient response to conventional therapies were included in this trial. Group A received three sessions of fractional CO2 laser at 1-month intervals during NB-UVB phototherapy which was performed three times a week for three months. Patients in group B only received phototherapy same as group A. The primary endpoint was the repigmentation rate. The mean age was 34.40 ± 11.93 years (range of 19-63). After the intervention, repigmentation was better in group A and the difference was statistically significant (P = 0.025). Patients in group A showed a better reduction of VASI score than group B (39.12 ± 27.81 Vs. 44.45 ± 30.77), although it was not statistically significant (P = 0.518). VETF and VIDA outcomes were slightly better in Group A than B, but it was not statistically significant (P = 0.317 and P = 0.180, respectively). The results of this study indicated that combining fractional CO2 laser with NB-UVB is superior to NB-UVB monotherapy, providing a promising modality in vitiligo patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoLasers, GasUltraviolet TherapyLow-Level Light TherapyHumansAdultMaleFemaleProspective StudiesMiddle AgedYoung AdultTreatment OutcomeCombined Modality Therapy

Stichwörter der Autor:innen

Fractional CO2 laserNB-UVBVitiligo

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Dermatology, Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Dermatology, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Zitieren

APA

Rokni, G. R., Malekan, M., Azade, S., Beyzaee, A. M., Heydari, K., Fallah, S., Kazeminejad, A., Zaresharifi, S., & Gholizadeh, N. (2025). Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial. Lasers in Medical Science, 40(1). https://doi.org/10.1007/s10103-025-04293-2

Vancouver

Rokni GR, Malekan M, Azade S, Beyzaee AM, Heydari K, Fallah S, et al. Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial. Lasers in Medical Science. 2025;40(1). doi:10.1007/s10103-025-04293-2

BibTeX
@article{Rokni2025,
  author = {Rokni, Ghasem Rahmatpour and Malekan, Mohammad and Azade, Sepide and Beyzaee, Amir Mohammad and Heydari, Keyvan and Fallah, Sahar and Kazeminejad, Armaghan and Zaresharifi, Shirin and Gholizadeh, Nasim},
  title = {Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial},
  journal = {Lasers in Medical Science},
  year = {2025},
  volume = {40},
  number = {1},
  doi = {10.1007/s10103-025-04293-2}
}
Kostenlos starten →